Gilead Sciences Inc.

(GILD) Trade

By |

Profile

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

Contact Information

Website: www.gilead.com
Email: investor_relations@gilead.com
Main Phone: +1 650 574-3000
Address: 333 Lakeside Drive
State: CA
City / Town: Foster City
Country: USA
Postal Code: 94404

Issuer Information

Exchange: NGS
CEO: John F. Milligan
Employees: 10000
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 75.51 $ 0.68 (0.91%)
Last Price 75.51 Change $ 0.68 Change % 0.91 Tick N/A
Bid 75.30 Bid Size 400.00 Ask 75.51 Ask Size 300.00
Open 74.79 High 75.93 Low 74.75 Prev Close 74.83
Last Trade Volume 9.6 mi 52 Wk Hi 89.54 52 Wk Low 64.27
Market Cap 97.9 bi Ex-Div Date Div Rate 2.28 Yield 3.0190
Shares 1,296,340,593.00 EPS (TTM) 1.69 PE Ratio 44.70 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 30 168
Number of Buys 15 79
Number of Sells 15 89
Net Activity 86723 -15903
Last 10 Buys Shares
Per Wold-Olsen 1,000
Per Wold-Olsen 1,000
Per Wold-Olsen 1,000
Carla A. Hills 1,000
Last 10 Sell Shares
John C. Martin 1,000
John F. Cogan 1,000
John C. Martin 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John F. Cogan 1,000
John C. Martin 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 105 105 105 105
Low Target Price Estimate 72 72 72 72
Mean Target Price Estimate 87.53 87.71 87.71 87.53
Standard Deviation 8.15 8.43 8.43 8.15
Date of Most Recent Estimate 05/31/18 05/03/18 05/03/18 06/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 12 11 12 12
Moderate Buy 1 1 1 1
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.81 1.85 1.81 1.81